I am deeply honored to present my poster at @DDWMeeting on the impact of submucosal fat in colonic ESD and to represent @bcm_gihep . I am grateful to @EndoscopyOthman for the opportunity, and to my mentors @GiJawaid and @FaresAyoubMD for their invaluable guidance and support.
Congratulations to our Top 12 #GoldenScope teams of #GIFellows who will be competing in the semifinals this September at the Senior Fellows Program at ASGE IT&T! Way to go and we'll see you later this year. #DDW2025
Liver stiffness in … acute liver failure?!
And how does it compare to acute on chronic liver failure
https://t.co/K7q9MKPHdU
1️⃣ACLF way stiffer
2️⃣Spleen stiffness normalish in ALF
3️⃣Stiffness associated with outcomes
#LiverTwitter
It’s a landmark in the history of NASH (MASH)
A positive trial: less fibrosis, less inflammation, lower LDL
Something to celebrate
https://t.co/x0GrR6XrHL
#livertwitter
Check out our report in @AGA_CGH where we discuss the estimated prevalence of Steatotic Liver Disease in the US, utilizing the newly adopted nomenclature #livertwitter@AASLDFoundation
https://t.co/w5Et5h9mJj
Read AASLD’s newly published Practice Guidance on Acute-on-chronic liver failure and the management of critically Ill patients with cirrhosis. Online at https://t.co/JfvTIAOznI #LiverTwitter@HEP_Journal
Liver transplantation, first performed in humans 60 years ago, is now the standard of care for patients with life-threatening liver disease. This new Review Article focuses on current developments in liver transplantation. Read it here: https://t.co/25nLH7yN90
🚨 @AASLDtweets Practice guidance on risk stratification and management of portal hypertension and varices in cirrhosis 🚨 JUST RELEASED
https://t.co/52y1BQo0km
#LiverTwitter#LiverX
1/
WHY are steroids used for alcoholic hepatitis?
SHOULD we?
WHAT is the deal with prednisolone vs prednisone?
WHERE did the discriminant function come from?
ARE you ready for a #tweetorial#livertwitter#medtwitter#meded#cirrhosis